Welcome to our dedicated page for Allium Medical Solutions news (Ticker: ALMDF), a resource for investors and traders seeking the latest updates and insights on Allium Medical Solutions stock.
Allmed Solutions develops biomedical technology for minimally invasive heart valve replacement, including the RoseDoc system developed with its subsidiary TruLeaf Medical. News about ALMDF centers on clinical activity for catheter-based valve procedures, first-in-human treatment updates, compassionate-care use in severe heart failure patients, and progress toward regulatory and commercial pathways for its valve-replacement technology.
Allmed Solutions (ALMDF) announced a first-in-human success using its RoseDoc system to fully replace a major heart valve via a single needle-stick catheter procedure, avoiding open-chest surgery.
The two compassionate-use patients had severe tricuspid regurgitation with no surgical options; a proprietary docking system was implanted ~3 months earlier, and final valve implantation produced immediate clinical improvement with both patients discharged within five days.
The company plans continued patient recruitment in India and expansion to sites in Israel, South Africa, and Uzbekistan as it advances toward global regulatory approval and commercialization.